ECOG performance status is an important risk factor for early mortality in metastatic castration-resistant prostate cancer (mCRPC). Patients with metastatic castration-resistant prostate cancer (mCRPC ...
Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
The era of value- and evidence-based care has come to oncology practice. Third-party payers approve treatment plans according to expert guidelines such as those of the National Comprehensive Cancer ...
Abbreviations: CCOP, Community Clinical Oncology Program; NCI, National Cancer Institute; NSCLC, non–small-cell lung cancer; QOL, quality of life; SD, standard deviation; VA, Veterans Affairs. On the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results